New Serialization Solution Combats Product Counterfeiting
In 2015, more than 20 million counterfeit pills and other medications were confiscated in one covert operation.1 It’s a problem that will continue to plague pharmaceutical companies—and other industries—because criminals can make a lot of money by falsifying drugs that are in high demand, in short supply, or are exorbitantly expensive for consumers.
In the United States, the Federal Drug Supply Chain Security Act (DSCSA) will require that pharmaceutical products be marked with a national drug code, serial number, lot number, and expiration date in machine- and human-readable formats. Application of these codes all prescription pharma products must be implemented by November 2017, and the pharma industry have adopted serialization as the technology to accomplish this.